Spring 2021 issue of Profiles is here!
Learn about students gaining valuable skills as helpline workers, the first female veterinarians to graduate from the CVM, the VDL tackling antimicrobial resistance, and much more. Read now
Whatever it takes
A couple crosses an ocean of obstacles to seek treatment at CVM for dog’s aggressive brain tumor. Read more
Beyond the buzz
Epigenetics clarifies the good, bad, and the ugly of cannabidiol — and countless other drivers for health. Read more
Research by Dr. Pam Skinner, associate professor, on CD8 T-cell immunotherapy to functionally cure HIV has been funded by MN-REACH, a joint effort between the University of Minnesota and the National Institutes of Health. As an NIH Research Evaluation and Commercialization Hub, MN-REACH is committed to improving health care by fostering the development and application of therapeutics, preventives, diagnostics, devices, and tools.
CVM researchers are constantly in the process of planning, writing, and submitting grant applications. For NIH grants,they go through a receipt and referral, peer review, and awards process, all of which can take nearly a year. If the process is successful, the researcher’s institution receives a “notice of award” and the researcher receives a congratulatory e-mail. Dr. Mather Kannan has been awarded NIH grants for “MicroRNA Regulation of CD39” and “MicroRNA Regulation of CD38 and Chemokine Genes in Human Airway Smooth Muscle.”